May 19, 2021 Price forecast | 2 weeks: 2.13% | 1 month: 1.39% | 3 months: 19.45% | Premium Forecast


BIOL stock forecast

Our latest prediction for Biolase Inc's stock price was made on the May 19, 2021 when the stock price was at 0.73$.

In the short term (2weeks), BIOL's stock price should outperform the market by 2.13%. During that period the price should oscillate between -11.57% and +18.38%.

In the medium term (3months), BIOL's stock price should outperform the market by 19.45%. During that period the price should oscillate between -42.07% and +59.78%.

Create a solid portfolio with BIOL

Add BIOL to your portfolio and optimize it!


About Biolase Inc

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

At the moment the company generates 26M USD in revenues.

On its last earning announcement, the company reported a loss of -0.43$ per share.

The book value per share is 0.99$

Biolase Inc website


Three months stock forecastMay 19, 2021


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
26M 29.00% -19M -73.70% -18M -0.43 - - 87M 0.99 -15M - -15M